29. Winkelstein JA, Marino MC, Johnston RB, Jr., Boyle J, Curnutte J, et al. (2000) Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79(3): 155–69. 30. Lomax KJ, Leto TL, Nunoi H, Gallin JI, Malech HL (1989) Recombinant 47- kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease. Science 245: 409–412. 31. Royer-Pokora B (1987) Novel approaches for cloning human genes: the chronic granulomatous disease (CGD). Dis. Markers 5: 57–58. 32. Jackson SH, Devadas S, Kwon J, Pinto LA, Williams MS (2004) T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol 5: 818–827. 33. Kishida KT, Pao M, Holland SM, Klann E (2005) NADPH oxidase is required for NMDA receptor-dependent activation of ERK in hippocampal area CA1. J Neurochem 94: 299–306. 34. Pollock JD, Williams DA, Gifford MA, Li LL, Du X, et al. (1995) Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 9: 202–209. 35. Jackson SH, Gallin JI, Holland SM (1995) The p47phox mouse knock-out model of chronic granulomatous disease. J Exp Med 182: 751–758. 36. Kaplan R (1992) Obstructive sleep apnoea and depression – diagnostic and treatment implications. Aust N Z J Psychiatry 26: 586–91. 37. Borak J, Cieslicki JK, Koziej M, Matuszewski A, Zielinski J (1996) Effects of CPAP treatment on psychological status in patients with severe obstructive sleep apnoea. J Sleep Res 5: 123–7. 38. Bardwell WA, Ancoli-Israel S, Dismdale JE (2001) Types of coping strategies are associated with increased depressive symptoms in patients with obstructive sleep apnea. Sleep 24: 905–9. 39. Sanchez AI, Buela-Casal G, Bermudez MP, Casa-Maldonado F (2001) The effects of continuous positive air pressure treatment on anxiety and depression levels in apnea patients. Psychiatry Clin Neurosci 55: 641–6. 40. Akashiba T, Kawahara S, Akahoshi T (2002) Relationship between quality of life and mood or depression in patients with severe obstructive sleep apnea syndrome. Chest 122: 861–5. 41. El-Sheikh M, Kelly RJ, Buckhalt JA, Hinnant JB (2010) Children’s sleep and adjustment over time: the role of socioeconomic context. Child Development 81: 870–883. 42. Row BW, Kheirandish L, Li RC, Hardie M, Bazan NG, et al. (2004) Platelet- activating factor receptor deficient mice are protected from experimental sleep apnea-induced spatial learning deficits. J Neurochem. 89: 189–196. 43. Kheirandish L, Row BW, Li RC, Brittian KR, Gozal D (2005) Apolipoprotein E deficient mice exhibit increased vulnerability to intermittent hypoxia-induced spatial learning deficits. Sleep 28: 1412–1417. 44. Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. Journal of Neuroscience Methods 11: 47–60. 45. Gerlai R, Clayton NS (1999) Analysing hippocampal function in transgenic mice: an ethological perspective. Trends Neurosci 22: 47–51. Review. 46. Montgomery KC (1955) The relation between fear induced by novel stimulation and exploratory behavior. J Comp Physiol Psychol 48: 254–60. 47. Eckeli AL, Dach F, Rodrigues ALS (2000) Acute treatment with GMP produces antidepressant-like effects in mice, Neuro Rep. 11: 1839–1843. 48. Zomkowsi ADE, Rosa AO, Lin J, Santos ARS, Calixto JB, et al. (2004) Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like- effect in the mouse forced swimming test, Brain Res. 1023: 256–263. 49. Kaster MP, Raupp I, Binfare´ RW, Andreatini R, Rodrigues SAC (2007) Antidepressant-like effect of lamotrigine in the mouse forced swimming test: evidence for the involvement of noradrenergic system. Euro J Pharmacol. 565: 119–124. 50. Miller FJ, Jr., Griendling KK (2002) Functional evaluation of nonphagocytic NAD(P)H oxidases, Methods Enzymol. 353: 220–233. 51. Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4- hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11: 81–128. 52. Day R, Gerhardstein R, Lumley A, Roth T, Rosenthal L (1999) The behavioral morbidity of obstructive sleep apnea. Prog Cardiovasc Dis 41: 341–354. 53. Bass JL, Corwin M, Gozal D, Moore C, Nishida H, et al. (2004) The effect of chronic or intermittent hypoxia on cognition in childhood: a review of the evidence. Pediatrics 114: 805–816. 54. Gozal D, Kheirandish-Gozal L (2008) The multiple challenges of obstructive sleep apnea in children: morbidity and treatment. Curr Opin Pediatr 20: 654–658. 55. Jun J, Savransky V, Nanayakkara A, Bevans S, Li J, et al. (2008) Intermittent hypoxia has organ-specific effects on oxidative stress. Am J Physiol Regul Integr Comp Physiol 295: R1274–R1281. 56. Li J, Savransky V, Nanayakkara A, Smith PL, O’Donnell CP, et al. (2007) Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J Appl Physiol 102: 557–56. 57. Angermu¨ller S, Islinger M, Vo¨lkl A (2009) Peroxisomes and reactive oxygen species, a lasting challenge. Histochem Cell Biol 131: 459–63. 58. Dro¨ge W (2002) The plasma redox state and ageing. Ageing Res Rev 1(2): 257–78. Review. 59. Kubota H, Fujioka Y, Yoshino H, Koji H, Yoshihara K (2010) Cardiac swinging calcified amorphous tumors in end-stage renal failure patients. Ann Thorac Surg 90: 1692–4. NADPH Oxidase and Intermittent Hypoxia 60. Santos CX, Tanaka LY, Wosniak J, Laurindo FR (2009) Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase. Antioxid Redox Signal 11: 2409–27. Review. 61. Akki A, Zhang M, Murdoch C, Brewer A, Shah AM (2009) NADPH oxidase signaling and cardiac myocyte function. J Mol Cell Cardiol 47: 15–22. 62. Berry CE, Hare JM (2004) Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 555: 589–606. 63. Muralikrishna Adibhatla R, Hatcher JF (2006) Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic Biol Med; 40: 376–387. 64. Yasui H, Hayashi S, Sakurai H (2005) Possible involvement of singlet oxygen species as multiple oxidants in p450 catalytic reactions. Drug Metab Pharmacokinet 20: 1–13. 65. Fukui T, Lassegue B, Kai H, Alexander RW, Griendling KK (1995) Cytochrome b-558 alpha-subunit cloning and expression in rat aortic smooth muscle cells. Biochim Biophys Acta 1231: 215–219. 66. Noh KM, Koh JY (2000) Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes. J Neurosci 20: RC111(1–5). 67. Tammariello SP, Quinn MT, Estus S (2000) NADPH oxidase contributes directly to oxidative stress and apoptosis in nerve growth factor-deprived sympathetic neurons. J Neurosci 20: RC53(1–5). 68. Sorce S, Krause KH (2009) NOX enzymes in the central nervous system: from signaling to disease. Antioxid Redox Signal 11: 2481–504. 69. Jang HJ, Hwang S, Cho KY, Kim do K, Chay KO, et al. (2008) Taxol induces oxidative neuronal cell death by enhancing the activity of NADPH oxidase in mouse cortical cultures. Neurosci Lett 443: 17–22. 70. Suh SW, Shin BS, Ma H, Van Hoecke M, Brennan AM, et al. (2008) Glucose and NADPH oxidase drive neuronal superoxide formation in stroke. Ann Neurol 64: 654–63. 71. Girouard H, Wang G, Gallo EF, Anrather J, Zhou P, et al. (2009) NMDA receptor activation increases free radical production through nitric oxide and NOX2. J Neurosci 29: 2545–52. 72. Groeger G, Mackey AM, Pettigrew CA, Bhatt L, Cotter TG (2009) Stress- induced activation of Nox contributes to cell survival signalling via production of hydrogen peroxide. J Neurochem 109: 1544–54. 73. Brennan AM, Suh SW, Won SJ, Narasimhan P, Kauppinen TM, et al. (2009) NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nat Neurosci 12: 857–63. 74. Bruce-Keller AJ, Gupta S, Parrino TE, Knight AG, Ebenezer PJ, et al. (2010) NOX activity is increased in mild cognitive impairment. Antioxid Redox Signal 12: 1371–82. 75. Ha JS, Lee JE, Lee JR, Lee CS, Maeng JS, et al. (2010) Nox4-dependent H2O2 production contributes to chronic glutamate toxicity in primary cortical neurons. Exp Cell Res 316: 1651–61. 76. Baran AS, Richert AC (2003) Obstructive sleep apnea and depression. CNS Spectr 8(2): 128–34. 77. Maneen MJ, Cipolla MJ (2007) Peroxynitrite diminishes myogenic tone in cerebral arteries: role of nitrotyrosine and F-actin. Am J Physiol Heart Circ Physiol 292: H1042–1050. 78. Nanetti L, Taffi R, Vignini A, Moroni C, Raffaelli F, et al. (2007) Reactive oxygen species plasmatic levels in ischemic stroke. Mol Cell Biochem 303: 19–25. 79. Serrano F, Kolluri NS, Wientjes FB, Card JP, Klann E (2003) NADPH oxidase immunoreactivity in the mouse brain. Brain Res 988: 193–198. 80. Vallet P, Charnay Y, Steger K, Ogier-Denis E, Kovari E, et al. (2005) Neuronal expression of the NADPH oxidase NOX4, and its regulation in mouse experimental brain ischemia. Neuroscience 132: 233–238. 81. Raz L, Zhang QG, Zhou CF, Han D, Gulati P, et al. (2001) Role of Rac1 GTPase in NADPH oxidase activation and cognitive impairment following cerebral ischemia in the rat. PLoS One 2010 5: e12606. 82. Chen H, Song YS, Chan PH (2009) Inhibition of NADPH oxidase is neuroprotective after ischemia-reperfusion. J Cereb Blood Flow Metab. 83. Zhang QG, Raz L, Wang R, Han D, De Sevilla L, et al. (2009) Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation. J Neurosci 29: 13823–13836. 84. Ohayon MM (2003) The effects of breathing-related sleep disorders on mood disturbances in the general population. J Clin Psychiatry 64: 1195–2000; quiz, 1274-6. 85. File SE (1992) Behavioural detection of anxiolytic action. In: Elliot JM, Heal DJ, Marsden CA, eds. Experimental Approaches to Anxiety and Depression. New York: John Wiley & Sons;. pp 25–44. 86. Pellow S, Chopin P, File SE, Briley M (1985) Validation of open-closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14: 149–67. 87. Hui-guo L, Kui L, Yan-ning Z, Yong-jian X (2010) Apocynin attenuate spatial learning deficits and oxidative responses to intermittent hypoxia. Sleep Med 11: 205–212. 88. Veasey SC, Davis CW, Fenik P, Zhan G, Hsu YJ, et al. (2004) Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep-wake brain regions. Sleep 27: 194–201. PLoS ONE | www.plosone.org 9 May 2011 | Volume 6 | Issue 5 | e19847